Stock listing

0HFR Stock Price, News, Filings & Events — Anavex Life Sciences Corp.

Selected listing: 0HFR · LSE · USD · GB

This page tracks Anavex Life Sciences Corp.'s 0HFR:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0HFR:LSE. 0HFR:LSE is the stock-level entry point for investors researching Anavex Life Sciences Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Anavex Life Sciences Corp. (AVXL) is a public company based in the United States, focusing on the development of therapies for neurodegenerative diseases. With a market capitalization of approximately $221.5 million, Anavex is engaged in advancing its research and clinical programs. The company aims to address significant unmet medical needs in the field of neuroscience.